| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | 890.59% | Roth MKM | → $6 | Reiterates | Buy → Buy |
| 03/07/2023 | 890.59% | Roth MKM | → $6 | Initiates Coverage On | → Buy |
| 12/29/2020 | 725.49% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
What is the target price for Tenax Therapeutics (TENX)?
The latest price target for Tenax Therapeutics (NASDAQ: TENX) was reported by Roth MKM on November 13, 2023. The analyst firm set a price target for $6.00 expecting TENX to rise to within 12 months (a possible 890.59% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tenax Therapeutics (TENX)?
The latest analyst rating for Tenax Therapeutics (NASDAQ: TENX) was provided by Roth MKM, and Tenax Therapeutics reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Tenax Therapeutics (TENX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenax Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenax Therapeutics was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
Is the Analyst Rating Tenax Therapeutics (TENX) correct?
While ratings are subjective and will change, the latest Tenax Therapeutics (TENX) rating was a reiterated with a price target of $0.00 to $6.00. The current price Tenax Therapeutics (TENX) is trading at is $0.61, which is within the analyst's predicted range.